United States · 
Who invested in MAP Pharmaceuticals?
MAP Pharmaceuticals's investors include Pequot Capital, Bay City Capital, Skyline Ventures, Brookside Capital and D.E. Shaw & Co., and 1 more on record.
United States · Series D startup
Who invested in MAP Pharmaceuticals
One round we have observed, with the 6 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$50Mraised across 1 round since 2007, from 1 source
- Latest round
- Series D, $50MMar 2007
- Investors
- 6
The rounds
- Mar 2007
The exit
ExitBuyerPriceWhen
From historical deal records. Wrong? Tell us.
Everyone who backed them
Pequot CapitalGrowth equity1round
Brookside CapitalHedge fund1round
D.E. Shaw & Co.Growth equity1round
PerseusHedge fund1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about MAP Pharmaceuticals
How much has MAP Pharmaceuticals raised?
MAP Pharmaceuticals has raised $50M across 1 round since 2007.
When did MAP Pharmaceuticals last raise?
MAP Pharmaceuticals's most recent round was a Series D of $50M in Mar 2007.
What was MAP Pharmaceuticals's biggest round?
Its most recent round, $50M in Mar 2007, is also its largest on record.
Who backed MAP Pharmaceuticals first?
MAP Pharmaceuticals's first round on record, in Mar 2007, was backed by Pequot Capital, Bay City Capital and Skyline Ventures and 3 others.
What stage is MAP Pharmaceuticals at?
MAP Pharmaceuticals's latest named round is a Series D, in Mar 2007.
Where is MAP Pharmaceuticals based?
MAP Pharmaceuticals is based in the United States.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.